Elissa is a senior laboratory technician with more than 15 years of experience working on preclinical cancer therapeutic development. She previously studied the role of MKK signaling in cancer and other vascular diseases, specifically retinopathies and peripheral vascular disease. She has experience in drug administration studies, surgical interventions and high-throughput genetic screening. Elissa joined the Grohar lab in 2016 to begin focusing on preclinical therapeutics for Ewing sarcoma.
Jenna graduated with a B.A. in Sociology with a minor in Zoology from University of Florida in 2008. She then earned an M.S. in Biomedical Science from Rosalind Franklin University of Medicine and Science. Jenna then went on to the Chicago Medical School at Rosalind Franklin University of Medicine and Science and earned her M.D. in 2013. In 2016, she completed her Pediatric Residency at Advocate Children’s Hospital, Oak Lawn, IL. Jenna is currently a clinic fellow in Pediatric Hematology/Oncology at Helen DeVos Children’s Hospital and a member of the Grohar Lab at Van Andel Research Institute.
Susan earned a B.S. in chemistry with an emphasis in biochemistry and a Master’s in business administration from Grand Valley State University. She has worked at VARI in the field of cancer biology for 13 years, and joined the Grohar Laboratory in September 2015.
Mitchell received his B.S. in Biophysics from the University of Michigan in 2012. He previously worked for the biotech startup Nymirum on drug discovery projects targeting RNA with small molecules using NMR spectroscopy and computational methods.
Brandon received his B.S. in Microbiology with a minor in Defense Studies and Leadership from Michigan State University.
Erik received his M.S. in Biology from Northern Michigan University, where he worked in the Upper Michigan Brain Tumor Center investigating protein-protein interactions on the surface of human glioblastoma multiforme (GBM) cells and capturing GBM tumor exosomes using flow cytometry.